Report Code : CVMI24072757 | Published Date : July 16, 2024
nan




Reasons To Buy

nan




Scope

nan

Key Players

  • Abbott Laboratories
  • Nestlé Health Science
  • Danone S.A.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
Europe Oncology Nutrition Market Report

Europe Oncology Nutrition Market Report

    1. Europe Oncology Nutrition Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Europe Oncology Nutrition Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Europe Oncology Nutrition Market Research Report - Preface
    1. 2.1 Europe Oncology Nutrition Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type of Cancer
      2. 2.1.2 By Nutritional Products
      3. 2.1.3 By Stage of Cancer
      4. 2.1.4 By Region
    3. Europe Oncology Nutrition Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type of Cancer, By Nutritional Products, By Stage of Cancer, By Country
    3. 3.3. Opportunities – By Type of Cancer, By Nutritional Products, By Stage of Cancer, By Country
    4. 3.4. Trends – By Type of Cancer, By Nutritional Products, By Stage of Cancer, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Europe Oncology Nutrition Market Research Report – DROTs Impact Analysis
    4. Europe Oncology Nutrition Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Europe Oncology Nutrition Market, By Type of Cancer, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Breast Cancer
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Lung Cancer
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Colorectal Cancer
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Prostate Cancer
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 5.5 Ovarian Cancer
      1. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.6 Pancreatic Cancer
      1. 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. 5.7 Others
      1. 5.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Europe Oncology Nutrition Market, By Nutritional Products, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Parenteral Nutrition (Amino Acids
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Lipids
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Carbohydrates)
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 6.5 Oral Nutritional Supplements (Protein Supplements
      1. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.6 High-Calorie Drinks)
      1. 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. 6.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
      1. 6.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Europe Oncology Nutrition Market, By Stage of Cancer, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Early-Stage Cancer
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Advanced-Stage Cancer
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Europe Oncology Nutrition Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Europe
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      2. 8.2 Europe Oncology Nutrition Market - Opportunity Analysis Index, By Type of Cancer, By Nutritional Products, By Stage of Cancer, and Region, 2024 - 2031
    9. Europe Europe Oncology Nutrition Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      9.1 By Type of Cancer Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Breast Cancer
      2. 9.1.2 Lung Cancer
      3. 9.1.3 Colorectal Cancer
      4. 9.1.4 Prostate Cancer
      5. 9.1.5 Ovarian Cancer
      6. 9.1.6 Pancreatic Cancer
      7. 9.1.7 Others
      9.2 By Nutritional Products Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Enteral Nutrition (Standard and Disease-Specific Formulas)
      2. 9.2.2 Parenteral Nutrition (Amino Acids
      3. 9.2.3 Lipids
      4. 9.2.4 Carbohydrates)
      5. 9.2.5 Oral Nutritional Supplements (Protein Supplements
      6. 9.2.6 High-Calorie Drinks)
      7. 9.2.7 Medical Foods (Nutritionally Complete Foods for Cancer Patients)
      9.3 By Stage of Cancer Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Early-Stage Cancer
      2. 9.3.2 Advanced-Stage Cancer
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 Germany
      2. 9.4.2 United Kingdom
      3. 9.4.3 France
      4. 9.4.4 Spain
      5. 9.4.5 Italy
      6. 9.4.6 Russia
      7. 9.4.7 Rest of Europe
      9.5 Europe Europe Oncology Nutrition Market – Opportunity Analysis Index, By Type of Cancer, By Nutritional Products, By Stage of Cancer, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 Europe Europe Oncology Nutrition Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (Germany)
      2. 9.7.2 Company 2 (United Kingdom)
      3. 9.7.3 Company 3 (United Kingdom)
    10. Competition Landscape
      10.1 Strategic Dashboard of Top Market Players
      10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 10.2.1 Abbott Laboratories
      2. 10.2.2 Nestlé Health Science
      3. 10.2.3 Danone S.A.
      4. 10.2.4 Fresenius Kabi AG
      5. 10.2.5 B. Braun Melsungen AG
    11. Data Collection Method and Research Approach
    12. Principal Presumptions and Acronyms